T1	Treatment 40 176	pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine
T2	Treatment 205 246	whole cell pertussis pentavalent vaccine.
T3	Treatment 308 623	combined diphtheria-tetanus-pertussis-inactivated poliovirus vaccines containing either acellular (Pa, SmithKline Beecham Biologicals) or whole cell (Pw, Pasteur Merieux Connaught) pertussis components, mixed with a Haemophilus influenzae type b polysaccharide polyribosylribitol phosphate-tetanus conjugate vaccine
T4	Treatment 1736 1762	tetanus toxoid combination
T5	Treatment 1798 1842	diphtheria, tetanus, whole cell pertussis-H.
T6	Treatment 1843 1904	influenzae b vaccine conjugated to tetanus toxoid combination
